Boston Scientific lands another date with FDA panel for Watchman stroke device

An FDA advisory panel is slated to convene yet again in October to consider the safety and efficacy of Boston Scientific's Watchman anti-stroke heart repair device. Boston Scientific, Food & Drug Administration (FDA)News Well, Cardiac Implants, Pre-Market Approval (PMA), Regulatory/Complianceread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news